Use of generic drugs on the rise, data show

Share this article:
Almost two-thirds of prescriptions filled for Medicare beneficiaries are for generic, rather than brand-name, drugs, according to government data. That proportion is higher than in the under-65 age group and helps lower the projected costs of the Medicare drug benefit. The Centers for Medicare and Medicaid Services, which runs the federal program for the elderly and disabled, found that 61% of seniors’ prescriptions were for generic medications in the third quarter, the third consecutive quarter of growth in generic drug use. The National Association of Chain Drug Stores was also expected to announce that use of generic drugs rose to almost 53% of privately insured Americans, from 48% in 2005. Increased use of generics has been given as one reason why the growth in US health care spending has slowed in recent years. Generic alternatives have also allowed seniors to delay reaching the Medicare benefit’s coverage gap, also known as the “doughnut hole,” or avoid it altogether. The agency encourages the use of generic drugs, according to The Wall Street Journal report.
Share this article:

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?